Cellubrevin homolog
AssigneeIncyte Pharmaceuticals, Inc.
InventorsSusan G. Stuart, Phillip R. Hawkins, Jeffrey J. Seilhamer
Life of this patent
Estimating the term…
Abstract
The present invention provides nucleotide and amino acid sequences that identify and encode a novel cellubrevin (CB). The present invention also provides for antisense molecules to the nucleotide sequences which encode CB, expression vectors for the production of purified CB, antibodies capable of binding specifically to CB, hybridization probes or oligonucleotides for detecting the upregulation of CB encoding nucleotide sequences, genetically engineered host cells for the expression of CB, diagnostic tests for activated, inflamed or diseased cells and/or tissues based on CB-encoding nucleic acid molecules and antibodies capable of binding specifically to CB.
Claims3
The complement of the polynucleotide sequence shown in SEQ ID NO:1.
A method for producing a cellubrevin (CB) having the amino acid sequence of SEQ ID NO:2, said method comprising the steps of:
- a) culturing a host cell transformed with an expression vector comprising the polynucleotide sequence shown in SEQ ID NO:1 under conditions suitable for expression of cb;
- and
- b) recovering CB from the cell culture.
A purified cellubrevin whose amino acid sequence is shown in SEQUENCE ID NO 2.
Dependencies are inferred from the claim text.